• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对Polo样激酶1的噻吩和咪唑并吡啶衍生物抑制剂的定量构效关系模型

QSAR models for thiophene and imidazopyridine derivatives inhibitors of the Polo-Like Kinase 1.

作者信息

Comelli Nieves C, Duchowicz Pablo R, Castro Eduardo A

机构信息

Facultad de Ciencias Agrarias, Universidad Nacional de Catamarca, Av. Belgrano y Maestro Quiroga, 4700 Catamarca, Argentina.

Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas INIFTA (UNLP, CCT La Plata-CONICET), Diag. 113 y 64, C.C. 16, Sucursal 4, 1900 La Plata, Argentina.

出版信息

Eur J Pharm Sci. 2014 Oct 1;62:171-9. doi: 10.1016/j.ejps.2014.05.029. Epub 2014 Jun 6.

DOI:10.1016/j.ejps.2014.05.029
PMID:24909730
Abstract

The inhibitory activity of 103 thiophene and 33 imidazopyridine derivatives against Polo-Like Kinase 1 (PLK1) expressed as pIC50 (-logIC50) was predicted by QSAR modeling. Multivariate linear regression (MLR) was employed to model the relationship between 0D and 3D molecular descriptors and biological activities of molecules using the replacement method (MR) as variable selection tool. The 136 compounds were separated into several training and test sets. Two splitting approaches, distribution of biological data and structural diversity, and the statistical experimental design procedure D-optimal distance were applied to the dataset. The significance of the training set models was confirmed by statistically higher values of the internal leave one out cross-validated coefficient of determination (Q2) and external predictive coefficient of determination for the test set (Rtest2). The model developed from a training set, obtained with the D-optimal distance protocol and using 3D descriptor space along with activity values, separated chemical features that allowed to distinguish high and low pIC50 values reasonably well. Then, we verified that such model was sufficient to reliably and accurately predict the activity of external diverse structures. The model robustness was properly characterized by means of standard procedures and their applicability domain (AD) was analyzed by leverage method.

摘要

通过定量构效关系(QSAR)建模预测了103种噻吩和33种咪唑并吡啶衍生物对以pIC50(-logIC50)表示的Polo样激酶1(PLK1)的抑制活性。采用多元线性回归(MLR),以替换法(MR)作为变量选择工具,对0D和3D分子描述符与分子生物活性之间的关系进行建模。将136种化合物分为几个训练集和测试集。两种拆分方法,即生物数据分布和结构多样性,以及统计实验设计程序D-最优距离,应用于数据集。训练集模型的显著性通过内部留一法交叉验证决定系数(Q2)的统计学更高值和测试集的外部预测决定系数(Rtest2)得到证实。从训练集中开发的模型,通过D-最优距离协议获得,并使用3D描述符空间以及活性值,分离出了能够较好地区分高和低pIC50值的化学特征。然后,我们验证了该模型足以可靠且准确地预测外部不同结构的活性。通过标准程序对模型稳健性进行了适当表征,并通过杠杆法分析了其适用域(AD)。

相似文献

1
QSAR models for thiophene and imidazopyridine derivatives inhibitors of the Polo-Like Kinase 1.针对Polo样激酶1的噻吩和咪唑并吡啶衍生物抑制剂的定量构效关系模型
Eur J Pharm Sci. 2014 Oct 1;62:171-9. doi: 10.1016/j.ejps.2014.05.029. Epub 2014 Jun 6.
2
Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors.作为强效和选择性波罗样激酶(PLK)抑制剂的咪唑并吡啶衍生物
Bioorg Med Chem Lett. 2009 Aug 15;19(16):4673-8. doi: 10.1016/j.bmcl.2009.06.084. Epub 2009 Jun 25.
3
Ligand-based pharmacophore modeling, atom-based 3D-QSAR and molecular docking studies on substituted thiazoles and thiophenes as polo-like kinase 1 (Plk1) inhibitors.基于配体的药效团建模、基于原子的三维定量构效关系以及对作为波罗样激酶1(Plk1)抑制剂的取代噻唑和噻吩的分子对接研究。
Comb Chem High Throughput Screen. 2014;17(10):848-58. doi: 10.2174/1386207317666141024152910.
4
Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding.具有改善溶解度和降低蛋白结合能力的高效polo样激酶1噻吩抑制剂的设计
Bioorg Med Chem Lett. 2009 Mar 15;19(6):1694-7. doi: 10.1016/j.bmcl.2009.01.094. Epub 2009 Jan 31.
5
QSAR-guided pharmacophoric modeling reveals important structural requirements for Polo kinase 1 (Plk1) inhibitors.QSAR 引导的药效团模型揭示了 Polo 激酶 1(Plk1)抑制剂的重要结构要求。
J Mol Graph Model. 2021 Dec;109:108022. doi: 10.1016/j.jmgm.2021.108022. Epub 2021 Sep 18.
6
Discovery of thiophene inhibitors of polo-like kinase.发现噻吩类 Polo 样激酶抑制剂。
Bioorg Med Chem Lett. 2009 Feb 1;19(3):1018-21. doi: 10.1016/j.bmcl.2008.11.041. Epub 2008 Nov 18.
7
Selectivity-determining residues in Plk1.Polo样激酶1(Plk1)中决定选择性的残基
Chem Biol Drug Des. 2007 Dec;70(6):540-6. doi: 10.1111/j.1747-0285.2007.00594.x. Epub 2007 Nov 13.
8
Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors.作为Polo样激酶1抑制剂的2-氨基-吡唑并吡啶的设计与合成
Bioorg Med Chem Lett. 2008 Oct 15;18(20):5648-52. doi: 10.1016/j.bmcl.2008.08.095. Epub 2008 Aug 29.
9
4,5-Dihydro-1H-pyrazolo[4,3-h]quinazolines as potent and selective Polo-like kinase 1 (PLK1) inhibitors.4,5-二氢-1H-吡唑并[4,3-h]喹唑啉类化合物作为有效的、选择性的 Polo 样激酶 1(PLK1)抑制剂。
Bioorg Med Chem Lett. 2010 Nov 15;20(22):6489-94. doi: 10.1016/j.bmcl.2010.09.060. Epub 2010 Sep 17.
10
Molecular modeling studies on imidazo[4,5-b]pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches.基于 3D-QSAR 和对接方法的咪唑并[4,5-b]吡啶衍生物作为 Aurora A 激酶抑制剂的分子模拟研究。
Eur J Med Chem. 2011 Jan;46(1):77-94. doi: 10.1016/j.ejmech.2010.10.017. Epub 2010 Oct 26.

引用本文的文献

1
Molecular Interactions Governing the Rat Aryl Hydrocarbon Receptor Activities of Polycyclic Aromatic Compounds and Predictive Model Development.多环芳烃类化合物调控大鼠芳香烃受体活性的分子相互作用及预测模型的建立。
Molecules. 2024 Sep 29;29(19):4619. doi: 10.3390/molecules29194619.
2
Linear Regression QSAR Models for Polo-Like Kinase-1 Inhibitors.针对类 polo 样激酶 -1 抑制剂的线性回归定量构效关系模型
Cells. 2018 Feb 14;7(2):13. doi: 10.3390/cells7020013.
3
Multiple Linear Regressions by Maximizing the Likelihood under Assumption of Generalized Gauss-Laplace Distribution of the Error.
在误差服从广义高斯 - 拉普拉斯分布的假设下,通过最大化似然函数进行多元线性回归。
Comput Math Methods Med. 2016;2016:8578156. doi: 10.1155/2016/8578156. Epub 2016 Dec 7.